141 related articles for article (PubMed ID: 34462420)
1. Silencing of O-linked N-acetylglucosamine transferase ameliorates hypercalcemia-induced neurotoxicity in renal failure by regulating EZH2/KLF2/CXCL1 axis.
Cao Y; Chen X; Sun H
Cell Death Dis; 2021 Aug; 12(9):819. PubMed ID: 34462420
[TBL] [Abstract][Full Text] [Related]
2. O-linked N-acetylglucosaminyltransferase OGT inhibits diabetic nephropathy by stabilizing histone methyltransferases EZH2 via the HES1/PTEN axis.
Fang N; Li P
Life Sci; 2021 Jun; 274():119226. PubMed ID: 33609540
[TBL] [Abstract][Full Text] [Related]
3. Drp1 activates ROS/HIF-1α/EZH2 and triggers mitochondrial fragmentation to deteriorate hypercalcemia-associated neuronal injury in mouse model of chronic kidney disease.
Sun H; Li X; Chen X; Xiong Y; Cao Y; Wang Z
J Neuroinflammation; 2022 Sep; 19(1):213. PubMed ID: 36050772
[TBL] [Abstract][Full Text] [Related]
4. P53 suppresses the progression of hepatocellular carcinoma via miR-15a by decreasing OGT expression and EZH2 stabilization.
You Z; Peng D; Cao Y; Zhu Y; Yin J; Zhang G; Peng X
J Cell Mol Med; 2021 Oct; 25(19):9168-9182. PubMed ID: 34510715
[TBL] [Abstract][Full Text] [Related]
5. Neurorescuing effect of Cinacalcet against hypercalcemia-induced nerve injury in chronic kidney disease via TRAF2/cIAP1/KLF2/SERPINA3 signal axis.
Cao Y; Xiong Y; Sun H; Wang Z
Cell Biol Toxicol; 2023 Oct; 39(5):1-17. PubMed ID: 35635602
[TBL] [Abstract][Full Text] [Related]
6. A protective role of nintedanib in peritoneal fibrosis through H19-EZH2-KLF2 axis via impeding mesothelial-to-mesenchymal transition.
Zhong W; Fu J; Liao J; Ouyang S; Yin W; Liang Y; Liu K
Int Urol Nephrol; 2024 Jun; 56(6):1987-1999. PubMed ID: 38097887
[TBL] [Abstract][Full Text] [Related]
7. Impact of OGT deregulation on EZH2 target genes FOXA1 and FOXC1 expression in breast cancer cells.
Forma E; Jóźwiak P; Ciesielski P; Zaczek A; Starska K; Bryś M; Krześlak A
PLoS One; 2018; 13(6):e0198351. PubMed ID: 29864144
[TBL] [Abstract][Full Text] [Related]
8. Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer.
Taniguchi H; Jacinto FV; Villanueva A; Fernandez AF; Yamamoto H; Carmona FJ; Puertas S; Marquez VE; Shinomura Y; Imai K; Esteller M
Oncogene; 2012 Apr; 31(15):1988-94. PubMed ID: 21892211
[TBL] [Abstract][Full Text] [Related]
9. O-GlcNAcylation regulates EZH2 protein stability and function.
Chu CS; Lo PW; Yeh YH; Hsu PH; Peng SH; Teng YC; Kang ML; Wong CH; Juan LJ
Proc Natl Acad Sci U S A; 2014 Jan; 111(4):1355-60. PubMed ID: 24474760
[TBL] [Abstract][Full Text] [Related]
10. LINC01232 Promotes Gastric Cancer Proliferation through Interacting with EZH2 to Inhibit the Transcription of KLF2.
Liu J; Li Z; Yu G; Wang T; Qu G; Wang Y
J Microbiol Biotechnol; 2021 Oct; 31(10):1358-1365. PubMed ID: 34409953
[TBL] [Abstract][Full Text] [Related]
11. Enhancer of zeste homolog 2 promotes renal fibrosis after acute kidney injury by inducing epithelial-mesenchymal transition and activation of M2 macrophage polarization.
Zhou X; Chen H; Hu Y; Ma X; Li J; Shi Y; Tao M; Wang Y; Zhong Q; Yan D; Zhuang S; Liu N
Cell Death Dis; 2023 Apr; 14(4):253. PubMed ID: 37029114
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA SNHG1 promotes bladder cancer progression by upregulating EZH2 and repressing KLF2 transcription.
Min J; Ma J; Wang Q; Yu D
Clinics (Sao Paulo); 2022; 77():100081. PubMed ID: 36087568
[TBL] [Abstract][Full Text] [Related]
13. miR-126-5p enhances radiosensitivity of lung adenocarcinoma cells by inhibiting EZH2 via the KLF2/BIRC axis.
Han F; Huang D; Meng J; Chu J; Wang M; Chen S
J Cell Mol Med; 2022 May; 26(9):2529-2542. PubMed ID: 35322532
[TBL] [Abstract][Full Text] [Related]
14. LINP1 promotes the progression of cervical cancer by scaffolding EZH2, LSD1, and DNMT1 to inhibit the expression of KLF2 and PRSS8.
Wu L; Gong Y; Yan T; Zhang H
Biochem Cell Biol; 2020 Oct; 98(5):591-599. PubMed ID: 32348690
[TBL] [Abstract][Full Text] [Related]
15. O-GlcNAc Transferase (OGT) Protects Cerebral Neurons from Death During Ischemia/Reperfusion (I/R) Injury by Modulating Drp1 in Mice.
Zhao J; Dong L; Huo T; Cheng J; Li X; Huangfu X; Sun S; Wang H; Li L
Neuromolecular Med; 2022 Sep; 24(3):299-310. PubMed ID: 34705256
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA SNGH7 Is activated by SP1 and exerts oncogenic properties by interacting with EZH2 in ovarian cancer.
Bai Z; Wu Y; Bai S; Yan Y; Kang H; Ma W; Zhang J; Gao Y; Hui B; Ma H; Li R; Zhang X; Ren J
J Cell Mol Med; 2020 Jul; 24(13):7479-7489. PubMed ID: 32420685
[TBL] [Abstract][Full Text] [Related]
17. Blockade of enhancer of zeste homolog 2 alleviates renal injury associated with hyperuricemia.
Shi Y; Xu L; Tao M; Fang L; Lu J; Gu H; Ma S; Lin T; Wang Y; Bao W; Qiu A; Zhuang S; Liu N
Am J Physiol Renal Physiol; 2019 Mar; 316(3):F488-F505. PubMed ID: 30566000
[TBL] [Abstract][Full Text] [Related]
18. EZH2-mediated inhibition of KLF14 expression promotes HSCs activation and liver fibrosis by downregulating PPARγ.
Du Z; Liu M; Wang Z; Lin Z; Feng Y; Tian D; Xia L
Cell Prolif; 2021 Jul; 54(7):e13072. PubMed ID: 34031939
[TBL] [Abstract][Full Text] [Related]
19. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
[TBL] [Abstract][Full Text] [Related]
20. Enhancer of zeste homolog 2 participates in the process of atherosclerosis by modulating microRNA-139-5p methylation and signal transducer and activator of transcription 1 expression.
Zheng X; Zhao X; Han Z; Chen K
IUBMB Life; 2021 Jan; 73(1):238-251. PubMed ID: 33331071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
